381 results on '"Keklik, Muzaffer"'
Search Results
52. Changes in CD34+ cell count in peripheral blood after whole blood donation
53. Characteristics and Risk Factors for Patients with BK Polyomavirus Infection After Hematopoietic Stem Cell Transplantation
54. Treatment with plasma exchange may serve benefical effect in patients with severe hyperbilirubinemia: A single center experience
55. The results of therapeutic plasma exchange in patients with severe hyperthyroidism: A retrospective multicenter study
56. The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: A single center experience from Turkey
57. Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis
58. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: A retrospective multicenter study
59. Pretransplant iron overload may be associated with increased risk of invasive fungal pneumonia (IFP) in patients that underwent allogeneic hematopoietic stem cell transplantation (alloHSCT)
60. Overlooked Prophylaxis of Hepatitis B in Patients Undergoing Hematopoietic Stem Cell Transplantation
61. Pretransplant Serum Fibrinogen Level may be a Predictive Marker on Chronic Graft-Versus-Host Disease (cGVHD) in Patients Having Undergone Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
62. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies COVID-19 Geçiren Türk Hematolojik Malignite Hastalarının Klinik Özellikleri ve Sonuçları
63. Impact of K-ras Mutation and C-myc Overexpression on the Prognosis of Diffuse Large B-Cell Lymphomas
64. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies
65. Comparison of centrifugal and membrane filtration modalities on therapeutic plasma exchange
66. Evaluation of chimerism test and genetic translocation results in ALL, AML and CML patients
67. KEMOTERAPİ İLE İLİŞKİLENDİRİLEN TOKSİK LÖKOENSEFALOPATİ: 2 OLGUNUN GÖZDEN GEÇİRİLMESİ
68. İnvaziv Duktal Meme Karsinomu Tedavisi Sonrası Gelişen Akut Myeloid Lösemi
69. Nakil Öncesi Yüksek Serum D-dimer Düzeyi Allojenik Hematopoietik Kök Hücre Nakli Yapılan Hastalarda Sağkalımı Belirlemede Prognostik Bir Belirteç Olabilir
70. Clinical Characteristics and Outcome of COVID-19 in Turkish Hematological Malignancy Patients
71. The Coincidence of Familial Mediterranean Fever and Hypereosinophilia in a Patient with Hereditary Elliptocytosis
72. Detection of Acute Lymphoblastic Leukemia Involvement in Pleural Fluid in an Adult Patient with Ataxia Telangiectasia by Flow Cytometry Method
73. Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy
74. An Evaluation of the Impact of Therapeutic Phlebotomy on Systemic Endothelial Functions in Polycythemic Patients with the Flow-Mediated Vasodilatation Method
75. Comparison of Plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC, and Trima Accel Cell Separators
76. Hematopoetik Kök Hücre Nakli Sırasında Gelişen Epileptik Nöbetlerin Değerlendirilmesi: Tek Merkez Deneyimi
77. REPLY FROM THE AUTHORS
78. Otolog hematopoetik kök hücre nakli yapılan yeni tanı multipl myelom hastalarında nakil sonrası erken granülosit koloni stimülan faktör uygulamasının engraftman ile ilişkisi
79. Evaluation of COVID‐19 fear and quality of life in patients with haematopoietic stem cell transplantation during the COVID‐19 pandemic.
80. PD-1 and PD-L2: Do they have prognostic value in lymphomas?
81. AKUT PROMİYELOSİTİK LÖSEMİ HASTALARINDA ATRAVE ARSENİK İLE ATRA VE İDARUBİSİN TEDAVİLERİNİNKARŞILAŞTIRILMASI
82. RISK FACTORS AND CLINICAL CHARACTERISTICS OF BK POLYOMAVIRUS INFECTION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
83. Retrospective evaluation of patients with primary mediastinal large B-Cell lymphoma: Real life experience
84. Evaluation of Epileptic Seizures Developed During Hematopoietic Stem Cell Transplantation: A Single Center Experience
85. AKUT PROMİYELOSİTİK LÖSEMİ HASTALARINDA ATRA VE ARSENİK İLE ATRA VE İDARUBİSİN TEDAVİLERİNİN KARŞILAŞTIRILMASI
86. VAJİNAL KANAMA İLE PRESENTE OLAN UTERUSUN DİFFÜZ BÜYÜK HÜCRELİ LENFOMASI : OLGU SUNUMU
87. OKULER TUTULUMLU MARJINAL ZONE LENFOMA’YA AIT IKI OLGU SUNUMU
88. WEGENER GRANÜLOMATOZİSİNİ TAKLİT EDEN NADİR BİR DİFFÜZ BÜYÜK B HÜCRELİ LENFOMA VARYANTI ; LENFOMATOİD GRANÜLOMATOZİS
89. Coincidence of three solid tumors in a patient with multiple myeloma
90. Pretransplant Serum Fibrinogen Level may be a Predictive Marker on Chronic Graft-Versus-Host Disease (cGVHD) in Patients Having Undergone Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT).
91. HEMATOLOG Hematopoetik Kök Hücre Nakli
92. HematologHematopoetik Kök Hücre Nakli
93. CLINICAL CHARACTERISTICS, POST-TREATMENT ASSESSMENT AND PROGNOSTIC FACTORS AFFECTING PATIENT SURVIVAL OF PATIENTS AT 65 YEARS OF AGE OR OLDER WITH HODGKIN LYMPHOMA: A RETROSPECTIVE MULTICENTER STUDY FROM TURKEY
94. Comparison of Plateletpheresis on the Haemonetics and Trima Accel Cell Separators
95. Do PD-1 and PD-L2 expression have prognostic impact in hematologic malignancies?
96. Overlooked Prophylaxis of Hepatitis B in Patients Undergoing Hematopoietic Stem Cell Transplantation.
97. Vitamin B12 deficiency among Newly-Arrived Syrian Refugees in Central Anatolia of Turkey
98. ÜLKEMİZDEKİ PAROKSİSMAL NOKTURNAL HEMOGLOBİNÜRİ HASTALARININ KLİNİK ÖZELLİKLERİNİN VE TEDAVİ SONUÇLARININ DEĞERLENDİRİLMESİ ÇOK MERKEZLİ BİR ÇALIŞMA
99. Ülkemizdeki paroksismal nokturnal hemoglobinüri hastalarının klinik özelliklerinin ve tedavi sonuçlarının değerlendirilmesi çok merkezli bir çalışma
100. Multipl myelomalı yaşlı hastaların klinik karakterleri ve tedavi sonuçları: Çok merkezli retrospektif çalışma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.